Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Contrast agent enhanced fluorescence imaging for early detection of arthritis

Not Accessible

Your library or personal account may give you access

Abstract

Fluorescence imaging in the near-infrared (NIR) spectral range following intravenous administration of optical contrast agents (dyes) has been investigated as a new tool for the detection of inflammatory joint diseases in an animal model in vivo. Our study reveals that NIR dyes of the cyanine class accumulate in inflammatory joints and could be used to detect early stages of joint inflammation.

© 2004 Optical Society of America

PDF Article
More Like This
Fluorescence imaging of experimental rheumatoid arthritis in vivo using a fast flying-spot scanner

J. Berger, J. Voigt, F. Seifert, B. Ebert, R. Macdonald, I. Gemeinhardt, O. Gemeinhardt, J. Schnorr, M. Taupitz, A. Vater, S. Vollmer, K. Licha, and M. Schirner
6631_32 European Conference on Biomedical Optics (ECBO) 2007

Early Detection of Rheumatoid Arthritis in Humans by Fluorescence Imaging

Bernd Ebert, Jörn Berger, Jan Voigt, Rainer Macdonald, Thomas Fischer, Kay-Geert Hermann, Kai Licha, and Michael Schirner
BTuF19 Biomedical Optics (BIOMED) 2008

NIR fluorescent contrast agents for detection of inflammation of lungs in vivo

Haiying Zhou, Shawn He, Sean Gunsten, Steven Brody, Walter Akers, and Mikhail Y. Berezin
AM2P.1 CLEO: Applications and Technology (CLEO:A&T) 2014

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.